ARCHIVES

340B Drug Discount Program: HRSA Defends Orphan Drug Rule

This article is from The Cancer Letter archive.

Vol. 40 No. 25 | June 20, 2014

Download PDF Visit The Full Archive

Related Articles

Joe Gray Moves To OHSU Knight Cancer Institute

January 21, 2011

Preventive Oncology Announcement Withdrawn For Modification

April 3, 1981

PIs On Both Sides of Screening Controversy Testified in Tobacco Trials.

October 26, 2007

As Amgen, Johnson & Johnson Battle Over Anemia Market, Medicare Enters The Fray

December 13, 2002

NALSO Members Urged To Police Selves, Adopt Ethics Code

August 4, 1978

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981